Margin gains mask deflation; organic growth flatlines as acceleration narrative crumbles
LTIMindtree reported 17% profit growth on currency tailwinds and a one-time gain, but organic revenue growth stalled at 6.4% constant-currency—flat versus FY2026—while new deals are priced 15–20% lower. Execution risk is high on the acceleration narrative.
+18% YoY
₹11,608 Cr | FX tailwind ~11.6 pp
+6.4% YoY
Flat vs FY2026's 6% baseline
+17.1% YoY
₹1,469 Cr | Includes ~₹200–300 Cr one-time gain
+120 bps YoY
17.8% OPM; +40 bps QoQ
The gap between headline and organic
LTIMindtree's reported numbers look strong: revenue +18% YoY, PAT +17%. But the organic picture is far weaker. Reported revenue growth of 18% includes an 11.6 percentage-point tailwind from INR depreciation; on a constant-currency basis, growth is just 6.4%—essentially flat versus FY2026's 6% baseline. Similarly, the PAT beat leans heavily on a one-time Voicing.AI fair-value gain of ~₹200–300 Cr (roughly 2% of revenue), which is excluded from ongoing earnings. Strip these out, and the operating performance is steady, not accelerating.
Management claims versus what the numbers actually say
Growth will accelerate through Q2 and into the second half, surpassing FY2026 growth levels.
Q1 shows 6.4% YoY CC growth—flat versus FY2026's 6% baseline. Requires ~8% CQGR (compound quarterly growth rate) for rest of year to beat FY2026 target.
Contradicted
Productivity headwinds in top accounts are behind us; new deals built on new pricing.
Old deals finalized at prior rates; new order book at 15–20% lower price points due to AI productivity gains. This is a new equilibrium, not a one-time cliff—ongoing headwind masked as transition.
Overstated
EBIT margin expanding; operational efficiency gains offset wage hikes.
Delivered OPM 17.8%, YoY +120 bps (from 14.3%). New Horizons program driving gains; forex offset wage inflation. Delivered as promised.
Supported
AI revenue USD 150M quarterly run rate; strong business outcomes and deal wins.
USD 150M (~1.3% of quarterly revenue) is nascent. Only 17 Voicing.AI implementations in 12 months. Strategic, but current traction years away from material revenue driver.
Supported (nascent)
QoQ sequential growth strong; expansion across segments.
QoQ growth 2.8% INR, but only 0.3% CC—well below historical 3–4% range. BFSI +3.2%, Tech +3.4%, but Consumer -0.7% dragged headline.
Overstated
What changed on this call
Growth narrative downgraded by results: Prior call promised acceleration surpassing FY2026's 6%. Q1 delivered 6.4% YoY CC—no acceleration, flat to down. Requires 8%+ CQGR rest of year; high execution risk.
Margin expansion narrowly confirmed: YoY EBIT margin +120 bps delivered. QoQ +40 bps despite wage hikes. New Horizons program working; sustainability at 15.5–16% range now credible.
Productivity deflation is now 'the new reference point': Management framed 15–20% lower pricing on new deals as transition, not ongoing headwind. New order book normalizes for this; delivering more work at same dollar value—a structural margin compression risk.
AI work still nascent but strategic: USD 150M quarterly run rate (1.3% of revenue). 17 Voicing implementations in 12 months. Small base; scaling years away, not a near-term driver of acceleration.
Guidance maintained; organic delivery lags: No formal cut, but organic growth lags prior implication of acceleration. Order book stable USD 1.7B but deflated in pricing. Execution risk high on India deal ramp, Randstad close, Consumer recovery.
Bull and bear ledger
Bull: Margin expansion (+120 bps YoY) real and sustainable via operational efficiency (New Horizons program, G&A optimization, vendor consolidation).
Bull: Top 5 customer growth +4.5% QoQ; sequential resilience in BFSI and Tech (double-digit YoY). Large client diversification improving.
Bull: Order book stable USD 1.7B with two large wins this quarter (automotive, industrial, financial consolidation deals). Deal pipeline strong.
Bull: Randstad acquisition (expected Q3) adds IT services revenue stream and talent outsourcing; 360-degree relationship with synergies.
Bear: Organic revenue growth flat at 6.4% YoY CC versus FY2026's 6% baseline. No acceleration narrative from prior call materialized. Requires 8%+ CQGR rest of year—execution risk high.
Bear: Pricing deflation (15–20% on new deals due to AI productivity) baked into order book. Same scope = lower revenue; operating leverage compression risk if productivity gains don't offset price declines.
Bear: Consumer segment -0.7% QoQ; India government large deal delayed from Q1 to Q2 due to hardware/memory supply chain issues. Recovery contingent on execution.
Bear: One-time Voicing.AI fair-value gain ~₹200–300 Cr inflates reported PAT. Adjusted PAT growth would be single digits. Earnings quality question.
Bear: Subcontracting expense jumped +320 bps YoY on vendor consolidation deals. Temporary per management, but margin risk if prolonged.
Bear: Macro headwinds persist (geopolitical, discretionary spend constraints). Limited appetite for discretionary capex. Clients prioritizing AI/revenue/margin initiatives only.
Risks, ranked by how much they should concern a holder
Growth acceleration doesn't materialize
HighQ1 showed 6.4% YoY CC growth (flat vs FY2026). Management's prior guidance implied growth would surpass FY2026's 6% baseline. To hit that target requires 8%+ CQGR rest of year. India deal delayed, Consumer still negative QoQ, discretionary spend constrained—catalysts are contingent. If macro remains sluggish or deal ramps slip, FY2027 growth misses.
Pricing deflation becomes permanent headwind
HighNew deals priced 15–20% lower than FY2026 due to AI productivity. Management frames this as 'new construct' (no more negotiation on pricing, only on ROI), implying this is structural and ongoing, not transitory. Order book stability masks revenue erosion: delivering more work for same dollar value. Margins depend on utilization and operational leverage, not pricing power. In recession, utilization falls and leverage reverses.
Randstad acquisition integration delays or underperforms
MediumExpected close Q3; regulatory approval on track but timeline risk. Deal structured as three legs (IT services, talent outsourcing, M&A synergies). Initial margin impact unclear. If integration drags, synergies slip into FY28, or M&A amortization is higher than guided, margins could disappoint.
India government deal supply chain issues persist
MediumLarge deal delayed from Q1 to Q2 due to hardware/memory shipments. Consumer segment already negative QoQ (-0.7%); further delays push recovery into H2 or beyond. If this deal doesn't ramp as expected, Consumer segment revenue growth disappears, and one key catalyst fails.
Earnings quality deterioration
MediumVoicing.AI fair-value gain of ~₹200–300 Cr boosted reported PAT by 2–3 pp. Going forward, fair-value changes flow through OCI (not P&L), reducing earnings volatility. But the precedent is set; willingness to invest in early-stage AI startups creates earnings noise and raises questions about organic profitability.
Hyperscaler FDE armies disintermediate consulting layer
MediumMicrosoft announced 6,000 FDEs + $2–3B investment. If hyperscalers capture AI deployment work (higher-margin phase), LTM's positioning as deployment partner weakens. LTM's 1,000 FDE initiative is early-stage; scale is years away. Competitive positioning risk.
How the street is positioned
LTIMindtree's stock closed at ₹4,362.1 on Jul 31—down 32.16% from its all-time high of ₹6,430, but up 23.59% from its 52-week low. The day-1 post-result pop (+2.16%) held partially through day 5 (+0.95%), signaling that the market found the quarter acceptable but not inspiring. The modest initial reaction—against a backdrop of reported 17% PAT growth—reflects street skepticism about the organic narrative: headlines impressed, but the underlying growth story disappointed. Trading above its 20-day and 50-day moving averages (₹4,077 and ₹3,982 respectively) but well below the 200-day average (₹4,944), the stock is in a recovery zone, not a momentum zone.
Ownership flows show institutional patience, not enthusiasm. FII holdings are stable at 6.63% (up just 0.12 pp QoQ from 6.51%), while DII has edged up to 17.01% (+0.1 pp from 16.91%). Promoters remain steady at 68.52% (down just 0.03 pp from 68.55%). No sign of large insider selling near the ATH, nor aggressive FII accumulation on the current drawdown. This is a 'hold and wait' stance—institutions are not raising positions despite the discount to ATH, nor dumping. They are pricing in execution risk on stated catalysts (India ramp, Randstad, growth acceleration) and waiting for Q2 results to confirm whether the narrative restarts or stalls further.
The debate
What to watch next
1 · India government deal ramp-up in Q2 (hardware delivery confirmation)
Management expects hardware shipments to accelerate in Q2, driving Consumer segment recovery. Monitor: actual Consumer segment QoQ and YoY growth in Q2; confirmation of supply chain improvements; whether India deal contributes the claimed uplift. If delayed again or undershoots, the entire growth acceleration narrative faces another dent.
2 · Q2 organic revenue growth (CC basis)—the arbiter of the debate
Q1 was 6.4% YoY CC; to beat FY2026 and validate acceleration, Q2 needs to show materially higher growth (~8%+). Monitor: reported revenue growth, CC revenue growth, segment-wise performance (especially BFSI, Tech, Consumer). If Q2 organic growth is still mid-single digits (6–7%), the acceleration thesis fails and FY2027 guidance misses.
3 · Randstad deal closure and IT services ramp trajectory
Expected close Q3 FY27. Monitor: regulatory approval progress; IT services revenue contribution in Q2 onwards; margin impact (accretion or dilution); integration costs. If closure slips to FY28 or IT services ramp lags, near-term revenue growth doesn't materialize and one key catalyst disappears.
The verdict
LTIMindtree delivered steady execution on margins—a win—but the company missed the growth acceleration narrative from the prior call. Reported numbers (18% revenue growth, 17% PAT growth) were inflated by currency tailwinds (~11.6 pp) and a one-time fair-value gain (~₹200–300 Cr). The organic reality is weaker: 6.4% YoY CC revenue growth, flat versus FY2026's 6% baseline, with pricing deflation (15–20% on new deals) baked into the order book. Management's confidence in H2 catalysts (India deal ramp, Randstad integration, Consumer recovery) is credible but contingent. Execution risk is high; delivery is uncertain.
Rating: Hold. The margin story (15.5%+ sustainable OPM) offers downside protection, and if the India deal and Randstad integration execute as guided, the growth acceleration thesis could restart. But near-term, the stock is fairly valued at ₹4,362 (down 32% from ATH, reflecting execution risk). Upgrade only if Q2 shows organic revenue growth >7% YoY CC and India deal ramps as expected. Until then, watch, don't reach.
The one number to track from here: Q2 organic revenue growth on a constant-currency basis. If it's 6–7% (flat to Q1), the FY2027 acceleration thesis is in doubt. If it's 8%+, the rerating has room to begin.
Weak organic growth masks AI pivot; execution risk on recovery claims
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met guided EBIT margin expansion (+120 bps YoY), stable order book, and deal wins. Missed growth acceleration narrative: Q1 CC growth 6.4% vs prior call's 'surpass FY2026 levels' claim.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
LTM delivered 18% YoY PAT growth but 6.4% organic revenue growth flat vs FY2026, signaling deceleration masked by FX and accounting gains. AI pivot is structural (USD 150M quarterly run rate, strong deal pipeline), but near-term growth acceleration risks (India deal ramp delayed, Consumer segment still negative QoQ, discretionary spend limited, 15–20% pricing deflation on new deals). Margins expanding via operational efficiency (New Horizons program) and forex offset wage hikes, but unsustainable if deflation persists. Randstad deal (Q3 expected) a multi-year bet requiring execution.
₹11608 Cr
Revenue · +18% YoY₹1468.6 Cr
Reported PAT · +17.1% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
0.3% QoQ growth in constant currency; strong sequential expansion
OVERSTATED2.8% QoQ INR growth, 0.3% CC growth is well below historical 3-4% range; BFSI +3.2%, Tech +3.4%, but Consumer -0.7% dragged headline
6.4% YoY constant currency growth reflects strong execution
MISS6.4% YoY CC growth is essentially flat vs FY2026's 6% guidance baseline and below historical 8-10% trends; no acceleration yet
Productivity headwinds in top accounts behind us; new deals built on new pricing
OVERSTATEDOld deals finalized at prior rates; new order book at 15-20% lower price points due to AI productivity (management admitted in Q&A), representing ongoing pricing deflation masked as 'new reference point'
EBIT margin 15.5% with 40 bps QoQ improvement and 120 bps YoY improvement
METDelivered OPM 17.8%, NPM 12.4%; discrepancy in EBIT vs OPM definition; forex offset wage hike per management, operational efficiency gain understated
AI revenue USD 150M quarterly run rate; measurable business outcomes and strong deal wins
METUSD 150M is ~1.3% of quarterly revenue (₹11,608 Cr = ~$1.4B); only 17 unique Voicing implementations in 12 months total; AI still nascent despite branding
Growth will accelerate through Q2 and into second half, surpassing FY2026 levels
MISSQ1 shows 6.4% YoY CC growth (no acceleration vs FY2026's 6%). Requires ~8%+ CQGR Q2-Q4 to beat FY2026. India deal ramp delayed into Q2, Consumer still negative QoQ, discretionary spend limited—execution risk high
Earnings quality
What changed since the last call
Growth narrative downgraded by numbers
DowngradePrior call: 'growth accelerate…surpassing FY2026 levels.' Q1 delivered 6.4% YoY CC growth vs FY2026's 6% — no acceleration, flat to down. Requires 8%+ CQGR rest of year to beat prior year; high execution risk.
Margin expansion narrowly confirmed
UpgradeYoY EBIT margin +120 bps delivered (15.5% vs 14.3% prior year Q1). QoQ +40 bps despite wage hikes. New Horizons program driving operational efficiency gains offset forex & subcon headwinds. Confidence in sustainable expansion at 15.5–16%+ range.
Productivity deflation framed as 'behind us'
NeutralTop client pricing cuts finalized in FY26. Q1 shows new deals priced 15–20% lower than prior year due to AI productivity — a new equilibrium, not a one-time cliff. Ongoing challenge masked as transition.
AI work still nascent, but strategic
NewUSD 150M quarterly run rate (1.3% of revenue) across Creative/Industrial/Business AI. 17 Voicing implementations in 12 months. Small base but growing; significant revenue contribution years away, not near-term driver.
Guidance maintained; delivery lags
NeutralNo formal guidance change, but organic growth lags implication of prior 'acceleration' message. Order book stable but deflated in pricing. Execution risk on deal ramps and macro uncertainty cited but not quantified.
The Q&A
Analysts pressed on whether productivity deflation is truly behind (it's not—embedded in new deals), whether top clients have permanently switched to AI-productivity pricing (yes, at 15–20% discount), and whether discretionary spend will recover (management uncertain; limited to AI/revenue/margin initiatives). Management held firm on growth acceleration thesis and margin resilience but offered limited specifics on macro timing. Confidence tone was defensive—emphasizing 'phase behind us' repeatedly rather than aggressive outlooks.
Growth acceleration and forecast — Sulabh Govila, Morgan Stanley
PartialBiggest segments (BFSI, Tech) in growth trajectory. Seasonal pass-through, Middle East geopolitical, India ramp delays are temporary. Expect Q2 momentum to continue despite macro headwinds. Productivity transition complete in top clients.
Vendor consolidation and subcontracting — Ashwin Mehta, Ambit Capital
AnsweredVendor consolidation transition deals where clients expect continuity of existing resources before handoff to LTM team. Temporary spike; will normalize as transition completes. Not indicative of broader trend.
Productivity gains and pricing — Hasmukh Vakharia, (implied)
AnsweredAI conversation moved from creation phase (last year) to deployment phase (now). New deals priced with AI productivity baked in; conversation has shifted from old pricing to new AI-enabled pricing construct. Largest deals won this quarter already factor in new pricing.
Order book and deal velocity — Hasmukh Vakharia
AnsweredOrder book has natural deflation adjustment (15% lower price points on new deals vs FY2026). Delivering more work for same dollar value. Geopolitical headwinds and limited discretionary spend constrain deal sizes. Preference for consistency over one-off spikes.
Consumer segment weakness — Rohit Thorat, Axis Capital
AnsweredYoY growth huge (+18.2%). QoQ decline due to delayed ramp-ups on large deals (India tax department, hardware shipments, memory chip delays). Marginal decline; positive on recovery once shipments accelerate.
North America momentum — Rohit Thorat
AnsweredTech services +3.4% QoQ, +10% YoY (double-digit). BFSI also back to sequential growth. Confident momentum will continue; North America has great traction built up.
Utilization and fresher hiring — Rohit Thorat
AnsweredTargeting 86–87% utilization range; currently mid-range, comfortable. Added 1,308 freshers Q1; expect similar numbers each quarter, possibly accelerate. AI-ready talent critical to strategy. Pyramid shape to shift from traditional to diamond over time.
Margins under growth acceleration — Sandeep Shah, Equirus
AnsweredOrganic margin to expand due to New Horizons initiatives. Randstad deal is 360-degree relationship (IT services + talent sourcing + M&A). No investment banking costs (direct transaction). Margins should track last year or better.
AI deflation scope — Sumeet Jain, CLSA
PartialProductivity headwinds in top accounts material in FY26. Now past that phase. New deals priced with AI productivity embedded. Conversation shifted to ROI and adoption, not model capability. Most top clients through phase already.
Five-year revenue doubling target — Sumeet Jain
PartialEuropean expansion via Randstad (Q3 onwards). APAC white space. AI work scaling (currently USD 150M quarterly). All new deals priced lower but with better margins. Limited discretionary spend now; expected to improve. Multiple levers to drive ambition.
Voicing.AI and Uniphore investments — Sushovan Nayak, Anand Rathi
AnsweredVoicing.AI: conversion of safe/preferred stock to equity triggered one-time fair-value gain through P&L. Going forward, fair-value changes in OCI. Voicing transforms contact centers and business processes; 17 implementations in 12 months. Uniphore: investment in equity round to accelerate SLM platform and partnership. Amounts not disclosed (private round, company confidentiality).
AI 1000 initiative timeline — Rahul Jain, Dolat Capital
Answered1,000 FDEs first cohort, Q2–Q3 majority skilling complete. Contextual/domain training in parallel with customers. Only few thousand FDEs globally available; massive opportunity for adoption acceleration. Not need 20k–30k; thousand makes significant impact.
Top client recovery confirmation — Vibhor Singhal, Nuvama
AnsweredSimple answer: yes. Headwinds complete; productivity transition done. Both clients grew this quarter; pipeline strong.
Randstad margin impact and tail rationalization — Vibhor Singhal
PartialRegulatory approval process on track; closure expected Q2 end or Q3 beginning. Transformation activities constrained until close. Assume prior shared numbers as safe baseline for now. No significant margin impact expected; deal has three legs (IT services, talent outsourcing, tech/digital M&A) with savings and synergies. Margin trajectory organic expansion continues; Q1-Q2 may see impact, but year margin should not degrade vs prior year.
Pricing deflation embedded in new deals — Prateek, HSBC
AnsweredFair characterization but not pure deflation. Same requirement priced 15% higher a year ago; now priced 15% lower due to new AI productivity. Price point is new reference point. Order book normalizes for this; delivering more work at same dollar value.
Deal productivity cuts history — Anmol Garg, DAM Capital
AnsweredAll productivity headwinds in top accounts last year; phase behind us. New deals priced per new productivity levels. Most existing big deals passed that phase. New book is new book; no regression.
Guidance
FY2027 organic growth better than FY2026's 6%
MediumRequires 8%+ CQGR from Q2–Q4. Q1 at 6.4% CC growth not supporting narrative yet. Depends on India deal ramp-up (Q2), Randstad IT services contribution (Q2 onwards), and Consumer recovery. Macro uncertainty and limited discretionary spend create downside risk.
EBIT margin to continue expansion; target 15.5%+ sustainable
HighNew Horizons program delivering 40 bps QoQ improvement Q1. Operational efficiency (G&A headcount reduction on AI adoption, vendor consolidation) offset wage hikes (~1%) and forex impacts. SG&A to stabilize at ~10% of sales (vs prior 11%–11.5% guidance).
Risks the call surfaced
Growth deceleration
HighQ1 6.4% YoY CC growth flat vs FY2026; requires 8%+ CQGR H2 to beat FY2026 target. India deal delayed, Consumer segment QoQ negative, discretionary spend limited. Execution risk on catalysts (Randstad, India ramp, macro recovery) high.
Pricing deflation
HighNew order book priced 15–20% lower than FY2026 due to AI productivity gains. Management frames as 'new pricing construct' but masks ongoing revenue headwind. Order book stable USD 1.7B but delivers more work at lower unit price. Margin expansion dependent on utilization/efficiency gains, not pricing power.
Customer concentration
MediumIndia government deal delayed due to supply chain issues (hardware, memory); ramp-up pushed to Q2 with timing risk. Randstad acquisition expected Q3; initial margin impact unclear (amortization, integration costs). Both are material to FY27 growth guidance; delays create miss risk.
Competitive pressure from hyperscalers
MediumMicrosoft announced 6,000 FDEs + $2–3B investment; other hyperscalers ramping similar initiatives. LTM AI 1000 FDE program positions LTM as complementary, but hyperscaler integration/consulting orgs could disintermediate. Long-term positioning risk if hyperscalers capture deployment-phase upside.
Macro/geopolitical headwinds
MediumMiddle East revenue <3% but delays Consumer ramp-ups. Discretionary spend remains limited (clients prioritizing AI/revenue/margin initiatives). Geopolitical escalation could further constrain capex budgets. Management indicated 'limited appetite' on discretionary spend; no sign of full recovery by H2 FY27.
Management
Score 6/10. Clear on strategy (AI pivot, three LoB model) but defensive on near-term execution. Repeatedly framed challenges as 'phase behind us' without quantifying path forward. Transparent on pricing deflation magnitude (15–20%) but initially presented as strategy, not headwind. Candid on macro risks; appropriately cautious on discretionary spend. Met margin expansion target (+120 bps YoY); delivered on EBIT margin guidance. Deal pipeline confirmed with named wins (though unquantified). Failed to deliver growth acceleration narrative—Q1 organic growth flat vs FY2026. Track record on prior guidance execution: Fit4Future program delivered results; New Horizons in early stages.
1 · Q2 FY27
India government large deal hardware delivery expected; ramp-up in revenue contribution
2 · Q2 FY27 onwards
Randstad IT services revenue ramp-up begins; transition to internal delivery model
3 · Q3 FY27
Randstad acquisition expected to close; full margin impact from synergies to begin
Randstad deal (Q3 expected) a multi-year bet requiring execution.
LTM Q1: consolidated PAT +17% YoY to ₹1,469 Cr, revenue +18%, EBIT margin expands 120 bps
PAT +17.1% YoY · revenue +18% · margins expanding
₹11,608 Cr
+18% YoY
₹1,468.6 Cr
+17.1% YoY
12.38%
+0.1pp YoY
₹49.46
LTM Limited (formerly LTIMindtree) opened FY27 with a broad-based operating beat in its first quarter as a renamed entity. Consolidated revenue rose 18.0% YoY (2.8% QoQ) to ₹11,608 Cr and net profit climbed 17.1% YoY (5.9% QoQ on the reported ₹1,387 Cr base) to ₹1,468.6 Cr, with basic EPS at ₹49.46. In USD terms growth was far more muted — revenue of $1,223.5 Mn was up just 6.1% YoY and a near-flat 0.1% QoQ (0.3% CC) — so the headline INR strength is heavily flattered by a weaker rupee (average USD/INR 94.87 vs 85.33 a year ago); constant-currency YoY revenue growth was 6.4%.
Q1 FY-2027 vs prior quarters
The cleaner read on profitability is operating, not reported. EBIT rose 27.9% YoY to ₹1,799 Cr and EBIT margin expanded to 15.5% (+120 bps YoY, +40 bps QoQ), driven by higher offshore mix (85.8%), improved utilisation (86.4%, +70 bps QoQ) and flat headcount (87,886, essentially unchanged QoQ). Below EBIT the print is noisier: a one-off ₹197.8 Cr fair-value gain on Voicing.AI convertible instruments (parked in other income) was more than offset by a ₹266 Cr forex loss (versus a ₹129 Cr gain a year ago), which is why reported PAT grew 17.1% — slower than EBIT — and PAT margin was flat YoY at 12.7%. Adjusting other income for the Voicing.AI gain alone would drag YoY PAT growth to roughly +5%, but that understates the quarter because the offsetting forex swing is equally one-off; the 27.9% EBIT growth is the truest signal of underlying momentum. Standalone tells a materially softer story (revenue +16.7%, PAT –4.3% YoY to ₹1,241 Cr, dented by a collapse in standalone other income to ₹51 Cr), so consolidated is the number to anchor on.
The stock went into the print at ₹4,037.2, up 2.4% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters; revenue is at a 6-quarter high.
Management did not provide specific quantitative guidance but expressed strong confidence in continuing its 'growth momentum' into the full year of FY2027, aiming for industry-leading growth. The long-term 'Lakshya'31' strategic framework targets a doubling of revenue in five years, driven by an AI-centric pivot and la
— This quarter: met
The result confirms rather than contradicts management's last-call framing. On the Q4 concall the CEO flagged a top BFSI client that had 'bottomed out'; the newly-renamed Financial Services segment (34% of revenue) is still down 2.5% YoY in CC but turned up +3.2% QoQ CC, consistent with a sequential recovery. Management gave no quantitative guidance but had targeted 'industry-leading growth' — 6.4% CC YoY revenue growth and 18% INR growth deliver on that qualitatively. Order inflow was $1.68 Bn (–0.3% QoQ, +3.1% YoY), TTM inflow $6.65 Bn, and the deal sheet is AI-led (AWS APT, Microsoft Agent 365 launch partner, multiple BlueVerse Voicing wins). Concurrently the Board approved reclassifying Nabha Power out of the promoter group and noted a pending EUR 160 Mn put-option deal for Randstad's Netherlands/Australia/France units — not yet concluded and not in these numbers.
What to watch
W1
Financial Services YoY CC trajectory — still –2.5% YoY; watch whether the +3.2% QoQ CC recovery turns YoY positive next quarter as the top BFSI client normalises.
W2
USD/CC revenue growth (6.1%/6.4% YoY) vs the flattering 18% INR print — durability of 'industry-leading growth' rests on CC, not rupee weakness.
W3
EBIT margin at 15.5% (+120 bps YoY) — whether offshore-mix/utilisation gains hold; and closure of the EUR 160 Mn Randstad acquisition, which could reshape FY27 numbers.
Source in ₹ million; converted to ₹ Cr (÷10). No exceptional item this quarter (prior-year FY26 Labour-Code exceptional does not touch either Q1 comparison). Consol other income includes a one-off ₹197.8 Cr fair-value gain on Voicing.AI convertibles (note 5), largely offset by a swing to ₹266 Cr forex loss (vs +₹129 Cr YoY). Consol PAT ₹1,468.6 Cr = shareholders ₹1,466.3 Cr + NCI ₹2.3 Cr. Renamed LTIMindtree→LTM Limited effective this period.